Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: A preliminary report from the Cincinnati Heart Project☆
References (26)
- et al.
Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects of infarct size on left ventricular function
J Am Coll Cardiol
(1989) - et al.
Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction
J Am Coll Cardiol
(1985) - et al.
Early versus late hospital arrival for acute myocardial infarction in the Western Washington thrombolytic therapy trials
Am J Cardiol
(1989) - et al.
Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Prehospital Study Group and Cincinnati Heart Project
Am Heart J
(1990) - et al.
Recent changes in management of acute myocardial infarction: implications for emergency care physicians (Editorial)
J Am Coll Cardiol
(1988) - et al.
The prehospital phase of acute myocardial infarction in the era of thrombolysis
Am J Cardiol
(1990) - et al.
Impact of field transmission of electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction
Am J Cardiol
(1990) - et al.
Prehospital diagnosis and treatment of acute myocardial infarction: a North-South prospective
Am Heart J
(1991) - et al.
Practical methods for computing power in testing multivariate general linear hypothesis
Computational Stat Data Analysis
(1984) - et al.
Myocardial infarction triage and intervention project phase I. Patients characteristics and feasibility of prehospital initiation of thrombolytic therapy
J Am Coll Cardiol
(1990)
Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study
Lancet
Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction
Lancet
Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
Lancet
Cited by (148)
False Activations for ST-Segment Elevation Myocardial Infarction
2016, Interventional Cardiology ClinicsCitation Excerpt :It is desirable to maximize the rate of appropriate CCL activations following the PH-ECG.15 Time to revascularization can be substantially reduced with a PH-ECG–based CCL activation strategy.16,17 However, emergent coronary angiography ± PPCI is a precious resource, particularly after working hours and on weekends when CCL staff are not on site.
Time to Treatment: Focus on Transfer in ST-Elevation Myocardial Infarction
2016, Interventional Cardiology ClinicsCitation Excerpt :The use of the prehospital ECG was strongly recommended because it significantly reduces the time to reperfusion. It gives the opportunity to make the diagnosis in the prehospital setting and alert the receiving hospital of an incoming STEMI patient.25–28 Diagnostic quality 12-lead ECGs can be obtained in the majority of patients.31
Comparison of outcomes of ambulance users and nonusers in ST elevation myocardial infarction
2014, American Journal of CardiologySystematic review and meta-analysis of the benefits of out-of-hospital 12-lead ECG and advance notification in ST-segment elevation myocardial infarction patients
2014, Annals of Emergency MedicineCitation Excerpt :After duplicates were removed, there were 1,338 unique citations. The full texts of 68 citations were screened,11,12,16,17,24-87 with 16 studies included in the review12,16,74-87 and 52 studies excluded.11,17,24-73 Two studies reported outcomes separately for patients who received primary percutaneous coronary intervention and fibrinolysis.16,75
The role of prehospital electrocardiograms in the recognition of ST-segment elevation myocardial infarctions and reperfusion times
2014, Journal of Emergency MedicineCellular technology improves transmission success of pre-hospital electrocardiograms
2013, American Journal of Emergency Medicine
- ☆
This study was supported part by research grants from Genentech, Inc., South San Francisco, Calif., and from The Penn Central Corporation, Cincinnati, Ohio.
- ∗
Coinvestigators listed in Appendix.